Phase II Study of Gemcitabine, Carboplatin, and Iniparib As Neoadjuvant Therapy for Triple-Negative and <i>BRCA1</i>/<i>2</i> Mutation–Associated Breast Cancer With Assessment of a Tumor-Based Measure of Genomic Instability: PrECOG 0105
Melinda L. Telli(Stanford University), James M. Ford(Palo Alto University), Robert W. Carlson(National Comprehensive Cancer Network), Barbara Haley(Shaanxi Research Association for Women and Family), Kristin C. Jensen(Shaanxi Research Association for Women and Family), Kirsten M. Timms(Myriad (Germany)), Judith Manola(Dana-Farber Cancer Institute), Lori J. Goldstein(Shaanxi Research Association for Women and Family), Shaker R. Dakhil(Cancer Center of Kansas), Bobbie Head(Shaanxi Research Association for Women and Family), Allison W. Kurian(Stanford University), Victor Abkevich(Shaanxi Research Association for Women and Family), Patrick Flaherty(Shaanxi Research Association for Women and Family), Pei-Jen Chang(Shaanxi Research Association for Women and Family), Elizabeth Schackmann(Shaanxi Research Association for Women and Family), Irene Wapnir(Stanford Medicine), Joseph A. Sparano(Tisch Cancer Institute), Shaveta Vinayak(Roswell Park Comprehensive Cancer Center), Anne-Renee Hartman(Shaanxi Research Association for Women and Family), Julia Reid(Shaanxi Research Association for Women and Family), Jafi A. Lipson(Shaanxi Research Association for Women and Family)
Cited by 226
Related Papers
A Draft Sequence of the Rice Genome ( <i>Oryza sativa</i> L. ssp. <i>japonica</i> )
|Science|2002|2.9k
Gene expression correlates of clinical prostate cancer behavior
|Cancer Cell|2002|2.5k
A Structured Tumor-Immune Microenvironment in Triple Negative Breast Cancer Revealed by Multiplexed Ion Beam Imaging
|Cell|2018|1.2k
Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer
|Clinical Cancer Research|2016|1.2k
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2021|1.1k